1-anilino-8-naphthalenesulfonate has been researched along with Diabetes Insipidus, Neurogenic in 1 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Diabetes Insipidus, Neurogenic: A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi-Tezuka, M | 1 |
| Kobayashi, J | 1 |
| Otabe, M | 1 |
| Hirai, A | 1 |
| Tashiro, J | 1 |
| Bujo, H | 1 |
| Morisaki, N | 1 |
| Saito, Y | 1 |
| Yoshida, S | 1 |
1 trial available for 1-anilino-8-naphthalenesulfonate and Diabetes Insipidus, Neurogenic
| Article | Year |
|---|---|
A clinical feature of hyperlipidemia in patients with central diabetes insipidus.
Topics: Administration, Intranasal; Cholesterol; Cholesterol, HDL; Deamino Arginine Vasopressin; Diabetes In | 2000 |